Feb 15th, 2024
Use of AI in Pharmacovigilance Automation
In the past few years, the domain of Pharmacovigilance (PV) (incl. Cosmetovigilance and Materiovigilance) […]
Feb 8th, 2024
Five Reasons to Adopt an AI-Powered Literature Surveillance Solution for Pharmacovigilance
In the rapidly evolving landscape of pharmacovigilance (PV), ensuring patient safety and health outcomes is non-negotiable. With the surge in…
Jan 16th, 2024
The need for a Safety Vigilance BPaaS Model
The challenges of Safety Vigilance in Pharma, Cosmetics, Devices, Vaccines and Nutraceuticals are creating a […]
Dec 15th, 2023
Understanding and Harnessing the Exponential Growth of Life Sciences Data
Navigating the Tsunami of Data According to a recent report by Arcadia Approximately 30% of […]
Nov 29th, 2023
Power your Literature Surveillance with AI-driven Automation
In the highly regulated landscape of pharmacovigilance (PV), ensuring patient safety and health outcomes is paramount. With increasing focus on…
Oct 26th, 2023
Unlocking the Potential of Drug Safety Automation for Small and Medium Pharma: People, Process, and System
The pharmaceutical industry is advancing at an unprecedented pace, with new drugs and therapies continually emerging to improve patient outcomes.…
Sep 14th, 2023
Mastering PV Literature Surveillance: How Datafoundry’s Literature Monitor Tackles the Complexity of Adverse Event Identification
Identifying adverse events from medical literature is one of the key tasks in pharmacovigilance (PV). It is also one of…
Aug 24th, 2023
Optimizing Pharmacovigilance Literature Search: Automated Multi-Source Articles Import
In the fast-evolving landscape of pharmacovigilance, staying ahead of potential adverse events (AEs) and ensuring patient safety is paramount. Manual…
May 30th, 2023
The Power of Active Surveillance: Safeguarding Lives Through Timely Signal Detection and Risk Management
Patient safety is of the utmost significance in the healthcare industry across the world. Every person seeking medical care is…